Behavioral Intervention for Reducing Sedentary Lifestyle in Prostate Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help prostate cancer survivors reduce their sitting time. Participants will be divided into two groups: one will receive a FitBit and support sessions with a movement specialist, while the other will receive only a FitBit and some public health resources. The researchers aim to determine if the support sessions help participants sit less and remain active over time. Ideal candidates are prostate cancer survivors not currently undergoing treatment and who sit for more than 8 hours a day. As an unphased trial, this study allows participants to contribute to innovative research focused on improving long-term health and activity levels.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since medical clearance from a primary health care provider is required, it's best to discuss your medications with them.
What prior data suggests that this behavioral intervention is safe for prostate cancer survivors?
Research shows that behavioral programs, like the one in this trial, are usually safe and manageable. Participants in similar studies often experience benefits such as reduced stress and improved mental health, with few serious side effects. For instance, mindfulness programs, which resemble this one, have helped reduce stress and anxiety in cancer survivors. Participants typically complete these programs without major issues.
In this trial, participants will use a FitBit and attend sessions with a movement expert. FitBits are commonly used and safe, and tracking daily activity with these devices usually doesn't cause problems. The sessions aim to be encouraging and helpful, enhancing well-being without any risk.
Overall, based on current research and the nature of this program, it is expected to be safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a unique approach to reducing sedentary lifestyles in prostate cancer survivors. Unlike traditional exercise recommendations, this trial combines wearable technology with personalized support. Participants use a FitBit Inspire 2 to track their activity and have access to a movement specialist for one-on-one sessions and group webinars. This method goes beyond just providing information, offering personalized behavioral support to help participants integrate more movement into their daily lives, which could lead to better long-term health outcomes.
What evidence suggests that this behavioral intervention is effective for reducing sedentary lifestyle in prostate cancer survivors?
Research has shown that certain activities can help cancer survivors sit less and be more active. In this trial, participants in the "Intervention" arm will use a FitBit with guidance from a movement expert, an approach proven to increase activity levels and reduce sitting time. This method often enhances physical abilities, mental well-being, and overall quality of life. Meanwhile, participants in the "Fitbit Only" arm will use a FitBit and access publicly available resources about active living. Studies suggest these activities can boost motivation to stay active and enhance social support. For prostate cancer survivors, these changes can lead to better health and a more active lifestyle.13678
Who Is on the Research Team?
Linda Trinh, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
This trial is for prostate cancer survivors in Canada who are mostly inactive, sitting for over 8 hours a day, and not currently undergoing radiation or chemotherapy. They should be ready to start becoming more active, have no severe heart issues or walking disabilities, and must not have had a serious fall recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week behavioural intervention including a FitBit and 6 behavioural support sessions with a movement specialist
Follow-up
Participants are monitored for changes in sedentary behaviour and physical activity at 6-months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- FitBit Only
- Intervention
Intervention is already approved in United States for the following indications:
- Loneliness in Older Adults
- Social Isolation
- Emotional Well-being
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator